High-dose cholecalciferol in critically ill patients with liver cirrhosis

J Intern Med. 2016 Mar;279(3):309-10. doi: 10.1111/joim.12457. Epub 2015 Dec 28.

Authors

K Amrein¹, J D McNally², H Dobnig^{1

3}, T R Pieber^{1

4}

Affiliations

¹ Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
² Division of Critical Care, Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
³ Schilddrüsen-Endokrinologie-Osteoporose Institut Dobnig, Graz, Austria.
⁴ Joanneum Forschungsgesellschaft GmbH, Graz, Austria.

PMID: 26707009
DOI: 10.1111/joim.12457

No abstract available

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Cholecalciferol / administration & dosage*
Critical Illness
Double-Blind Method
Female
Humans
Liver Cirrhosis / drug therapy*
Male
Middle Aged
Vitamins / administration & dosage*

Substances

Vitamins
Cholecalciferol